P. Marcos Rodriguez (A Coruña, Spain), D. Stolz (Basel, Switzerland)
High serum HIF-1a levels are associated with intensive respiratory support in community acquired pneumonia
N. Carrion Collado (Valencia, Spain), A. Comes Raga (Valencia, Spain), F. Sanz Herrero (Valencia, Spain), G. Marcaida Benito (Valencia, Spain), E. Fernández-Fabrellas (Valencia, Spain)
|   |
A population-based study to estimate the incidence rate of hospitalized community-acquired pneumonia in adults in Greece
A. Liapikou (Athens, Greece), V. Kossyvaki (Athens, Greece), J. Skiadas (Athens, Greece), D. Menegas (Athens, Greece), C. Méndez (Madrid, Spain), E. Begier (Collegeville, United States), B. D. Gessner (Collegeville, United States), C. Schwarz (Vienna, Austria), H. Milionis (Ioannina, Greece), V. Tsimihodimos (Ioannina, Greece), A. Konstantinidis (Ioannina, Greece), G. Baxevanos (Ioannina, Greece), T. Argiriadou (Kavala, Greece), C. Terrovitou (Kavala, Greece), M. Toumbis (Athens, Greece), S. Egnatia Group (Athens, Greece)
| |
Activity and isoferment spectrum of serum lactate dehydrogenase in patients with community-acquired pneumonia associated with non-alcoholic fatty liver disease
R. Razumnyi (Dnipro, Ukraine)
| |
Impact of isolation for the suspicion of COVID-19 on bacterial pneumonia patients
A. Tamura (Tokyo, Japan), M. Murakami (Tokyo, Japan), H. Okamoto (Tokyo, Japan), T. Jinta (Tokyo, Japan)
| |
Adiponectin in patients with community-acquired pneumonia: a prospective cohort study
A. Dungu (Hilleroed, Denmark), C. Ryrsø (Hilleroed, Denmark), M. Hegelund (Hilleroed, Denmark), A. Sejdic (Hilleroed, Denmark), A. Jensen (Hilleroed, Denmark), P. Kristensen (Hilleroed, Denmark), R. Krogh-Madsen ( Hvidovre, Denmark), D. Faurholt-Jepsen (Copenhagen, Denmark), B. Lindegaard (Hilleroed, Denmark)
| |
Analysis of complications of community-acquired pneumonia (CAP) in Anti-Terrorist Operation / Joint Forces Operation (ATO / JFO) participants
N. Popenko (Kyiv, Ukraine)
| |
Antioxidative stress markers in obese patients with community-acquired pneumonia
T. Dumitras (Chisinau, Republic of Moldova), D. Fetco-Mereuta (Chisinau, Republic of Moldova), S. Matcovschi (Chisinau, Republic of Moldova), L. Grib (Chisinau, Republic of Moldova), L. Andronache (Chisinau, Republic of Moldova), V. Cascaval (Chisinau, Republic of Moldova), V. Pantea (Chisinau, Republic of Moldova), V. Gudumac (Chisinau, Republic of Moldova)
| |
Delta Neutrophil Index, C-Reactive Protein and IL-8 as Markers of Sepsis
P. Peneva (Varna, Bulgaria), S. Nikolova (Varna, Bulgaria), Y. Bocheva (Varna, Bulgaria)
| |
Changes in the pathogen spectrum of hospitalized adults with community-acquired pneumonia in Fujian Province: a multicenter, prospective study from 2012 to 2018
F. Wu (fuzhou, China), J. Wu (fuzhou, China), N. Xu (fuzhou, China), M. Lin (fuzhou, China), W. Yue (fuzhou, China), Y. Chen (fuzhou, China), H. Li (fuzhou, China)
| |
Phenotypic characteristics of Streptococcus pneumoniae in patients admited to intensive care unit due to bacteremic pneumococcal pneumonia
F. Sanz Herrero (València, Spain), L. Ruiz Iturriaga (Barakaldo, Bizkaia, Spain), M. García Clemente (Oviedo, Spain), P. España Yandiola (València, Spain), L. Serrano Fernández (Barakaldo, Bizkaia, Spain), N. Carrión Collado (València, Spain), J. Herrero Huertas (Madrid, Spain), R. Zalacaín Jorge (Barakaldo, Bizkaia, Spain), E. Fernández-Fabrellas (Barakaldo, Bizkaia, Spain)
| |
Host transcriptomic signature for infection in patients with suspicion of LRTI undergoing bronchoscopy
D. Schumann (Basel, Switzerland), A. Hoheisel (Basel, Switzerland), K. Jahn (Basel, Switzerland), N. Khanna (Basel, Switzerland), M. Herrmann (Basel, Switzerland), A. Darie (Basel, Switzerland), S. Ragozzino (Basel, Switzerland), S. Kuster (Basel, Switzerland), W. Strobel (Basel, Switzerland), H. Hirsch (Basel, Switzerland), M. Tamm (Basel, Switzerland), D. Stolz (Basel, Switzerland)
| |
Model-Based Dosing Optimization of Teicoplanin in Critically Ill Patients
S. KANG (Seoul, Republic of Korea), H. Jo (Seoul, Republic of Korea), E. Chung (Seoul, Republic of Korea), S. Rhie (Seoul, Republic of Korea), C. Choi (Seoul, Republic of Korea)
| |
Serum copeptin and Serum albumin as markers of severity for community acquired pneumonia
V. Padashetti (Kalaburgi, India), M. Pa (Kalaburgi, India), J. Bs (Kalaburgi, India)
| |
Late Breaking Abstract - Real-world effectiveness of remdesivir for hospitalized patients with COVID-19: systematic review and meta-analysis
L. Barnieh (New York, United States), R. Gottlieb (Dallas, United States), J. Malin (Cologne, Germany), R. Paredes (Badalona, Spain), R. Beckerman (New York, United States), R. Gupta (Uxbridge, United Kingdom), J. Jarrett (Uxbridge, United Kingdom), S. Jeyakumar (New York, United States), N. Smith (New York, United States), A. Texeiro-Pinto (Sydney, Australia)
| |
Validation of IDSA/ATS guidelines for ICU admission in very elderly patients with community-acquired pneumonia
C. Cilloniz Campos (Barcelona, Spain), M. Ferrer (Barcelona, Spain), J. Pericas (Barcelona, Spain), L. Serrano (Bizkaia, Spain), R. Mendez (Valencia, Spain), R. Menendez (Valencia, Spain), L. Ruiz (Bizcaya, Spain), A. Torres (Barcelona, Spain)
| |
ESTIMATING THE RISK OF BACTEREMIA IN HOSPITALIZED PATIENTS WITH PNEUMOCOCCAL PNEUMONIA
L. Serrano Fernandez (Barakaldo (Bizkaia), Spain), L. Ruiz Iturriaga (Barakaldo (Bizkaia), Spain), S. Perez Fernandez (Barakaldo (Bizkaia), Spain), P. España Yandiola (Galdakao (Bizkaia), Spain), C. Cilloniz (Barcelona, Spain), B. Gonzalez Quero (Barakaldo (Bizkaia), Spain), A. Rezola Carasusan (Barakaldo (Bizkaia), Spain), A. Uranga (Galdakao (Bizkaia), Spain), A. Torres Martí (Barcelona, Spain), R. Zalacain Jorge (Barakaldo (Bizkaia), Spain)
| |
Covid -19 pneumonia in women: what are the particularities?
N. Ella (nabeul, Tunisia), A. Narjes (nabeul, Tunisia), L. Manel (nabeul, Tunisia), G. Nada (nabeul, Tunisia), K. Slim (nabeul, Tunisia), B. Mechaal (nabeul, Tunisia), C. Imen (nabeul, Tunisia), B. Khaled (nabeul, Tunisia), G. Hedia (nabeul, Tunisia)
| |
Neutrophil gelatinase-associated lipocalin for predicting clinical stability in patients with community-acquired pneumonia
R. Lin (GuangZhou, China), M. Xue (GuangZhou, China), T. Zhang (Macau, China), Y. Zeng (GuangZhou, China), W. Cao (GuangZhou, China), S. Wu (GuangZhou, China), M. Liu (GuangZhou, China), N. Li (GuangZhou, China), P. Zheng (GuangZhou, China), H. Hu (GuangZhou, China), C. Huang (Macau, China), B. Sun (GuangZhou, China)
| |
Forced oscillation technique used for monitoring of covid-19 pneumonia
I. Taivans (Riga, Latvia), L. Grima (Riga, Latvia), N. Jurka (Riga, Latvia), G. Strazda (Riga, Latvia), V. Gordjusina (Riga, Latvia)
| |
Interstitial changes after severe SARS-CoV-2 Infection
A. Llanos Gonzalez (Santa Cruz de Tenerife, Spain), V. Hernández García (Santa Cruz de Tenerife, Spain), H. González Expósito (Santa Cruz de Tenerife, Spain), J. Bonilla Arjona (Santa Cruz de Tenerife, Spain), P. Pérez De Armas (Santa Cruz de Tenerife, Spain), N. Mesa Leóon (Santa Cruz de Tenerife, Spain), M. Gómez Gil (Santa Cruz de Tenerife, Spain), J. Estonell Erill (Santa Cruz de Tenerife, Spain), O. García Hernández (Santa Cruz de Tenerife, Spain), M. Cruz Díaz (Santa Cruz de Tenerife, Spain), O. Acosta Fernández (Santa Cruz de Tenerife, Spain)
| |